Successful Launch of Mechanism of Action Based Pipeline Reports by DelveInsight

New Delhi, India, July 30, 2014 --(PR.com)-- After a successful launch of Drug and Indication Reports under Pharm Delve Series, DelveInsight has come up with Pipeline Reports under brand name Pharm Insights covering 700+ Mechanism of Action reports.

Mechanism of Action Based Reports is a one of a kind report which will provide comprehensive insights about pipeline drugs across this mechanism of action (MOA). This report provides information on the therapeutic development based on the certain MOA dealing with the target, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the company’s information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

“In this highly competitive world, everybody wants to understand the pace of their competitors. Mechanism of Action based reports is the key for them,” said Ms Mridhu Verma, Analyst at DelveInsight.

These reports can be available through leading resellers such as Report Linker’s, Report Buyer’s, ASD Media and Report stack or you can directly contact at info@delveinsight.com